Product Information
PREGABALIN 300 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0658 per EA under NDC 31722061790. Its NADAC has been published 322 times since Apr 29, 2020.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722061790
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
Generic (ANDA)
FDA Application
ANDA206912On Market Since
10/8/2019
Price Statistics
The NADAC for PREGABALIN 300 MG CAPSULE has been published 322 times since Apr 29, 2020, and over the history we have for it it has declined 66.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0658 per EA |
|---|---|
| All-time high | $0.1964 (Jun 10, 2020) |
| All-time low | $0.0628 (Nov 20, 2024) |
| 52-week high | $0.0803 |
| 52-week low | $0.0652 |
| Median price | $0.0985 |
| Average price | $0.1054 |
| Largest weekly change | +30.8% (Aug 21, 2024) |
| Weeks tracked | 322 |
| Tracking since | Apr 29, 2020 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PREGABALIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.0658 per EA (NDC 31722061790), effective Jun 24, 2026.
How has the price of PREGABALIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 66.3%. It has been tracked across 322 weekly CMS publications since Apr 29, 2020.
What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?
Since Apr 29, 2020, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0628 (Nov 20, 2024) to a high of $0.1964 (Jun 10, 2020), with a median of $0.0985 per EA.
Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?
10 NADAC-published products share the same active ingredient, strength, and dosage form as PREGABALIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures PREGABALIN 300 MG CAPSULE?
PREGABALIN 300 MG CAPSULE (NDC 31722061790) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification